Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales—authors’ response
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Antimicrobial Chemotherapy"
DOI: 10.1093/jac/dkac072
Abstract: 7 days (Figure 1). These clearance and terminal half-life values therefore make it difficult to reconcile the presented PTA curves and model parameter estimates, in particular for the older (7–14 and 14–28 day) age groups.… read more here.
Keywords: flomoxef neonates; neonates extending; options treatment; neonatal sepsis ... See more keywords